Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis. (Q51994415)

19 April 2018

title

Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis. (English)

1 reference

19 April 2018

1 reference

19 April 2018

author name string

McIntyre PB

series ordinal

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

19 April 2018

number of pages

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 April 2018

volume

1 reference

19 April 2018

issue

21-22

1 reference

19 April 2018

page(s)

2953-2964

1 reference

19 April 2018

A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991‐1997: Report of the Immunization Monitoring Program–Active (IMPACT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Diagnostic testing and discharge coding for whooping cough in a children's hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Immunogenicity of a three-component acellular pertussis vaccine administered at birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

An economic evaluation of universal pertussis vaccination in Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Economic evaluation of a new acellular vaccine for pertussis in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

Survey of pertussis morbidity in adults in western Sydney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.057

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.11.057

1 reference

19 April 2018

1 reference

19 April 2018